查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197873

氧疗设备市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Oxygen Therapy Equipment Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

氧疗市场的主要增长因素包括吸烟人数增加、呼吸系统疾病患病率增加以及氧疗技术进步。

呼吸系统疾病患病率上升是预计在预测期内推动整体市场增长的主要因素。 根据世界卫生组织（WHO）公布的数据，全球疾病负担调查显示，2016年全球慢性阻塞性肺病（COPD）病例达2.51亿例。 由于许多国家的吸烟率上升和人口老龄化，预计 COPD 病例将在全球范围内增加。

此外，美国过敏、哮喘和免疫学会估计，2016 年美国约有 8.3% 的儿童患有哮喘。 它是儿童中最常见的慢性疾病。 吸烟是大多数呼吸道疾病的主要危险因素。 2016 年，美国疾病控制与预防中心 (CDC) 估计，每 100 名 18 岁及以上的美国成年人中就有超过 15 人吸烟。 因此，由于呼吸系统疾病患病率上升，预计在预测期内市场将呈现巨大需求。

氧疗仪市场趋势

按应用来看，慢性阻塞性肺病 (COPD) 预计在预测期内将占据最大的市场份额

慢性呼吸系统疾病是指长期影响气道和肺部其他部位的疾病。 呼吸道症状是转诊给初级卫生保健中心医生和医生的主要原因之一。 根据 2018 年全球哮喘报告，慢性呼吸道疾病影响全球超过 10 亿人。 据世界卫生组织称，慢性阻塞性肺病的根本原因是吸烟，它影响着世界上很大一部分人口。 此外，根据 2017 年发表在《柳叶刀呼吸医学》上的一篇论文，2015 年全球估计有 3.2 人死于慢性阻塞性肺病。 当 COPD 导致血氧水平低时，需要进行长期氧疗。 因此，慢性阻塞性肺病患病率的上升有望带来氧疗设备市场的高速增长，并创造对氧疗设备的巨大需求。

预计在预测期内北美将占据最大的市场份额

由于呼吸系统疾病患病率上升以及医疗保健基础设施完善，预计美国将成为最大的氧疗设备市场。 此外，该国的人均医疗支出正在增加，并且由于失业率下降，预计在预测期内会增加。 吸烟是大多数呼吸道疾病的主要危险因素。 2016 年，美国疾病控制与预防中心 (CDC) 估计，每 100 名 18 岁及以上的美国成年人中就有超过 15 人吸烟。 据信，由于高吸烟率和人口老龄化，COPD 病例在美国有所增加。 在过去的几十年里，制氧机的设计和功能有了很大的进步。 新一代便携式製氧机设计轻便、安静且节能。 由于体积小、成本低、携带方便等优点，便携式製氧机的使用正在迅速扩大。 在此背景下，市场有望高速增长。

氧疗设备市场竞争分析

由于存在少数大型参与者，该市场是一个整合市场。 一些市场参与者包括 Allied Healthcare Products, Inc、CAIRE Inc、DeVilbiss Healthcare、Fisher & Paykel Healthcare Limited、Hersill、Invacare Corporation、Koninklijke Philips N.V.、Smiths Medical、TECNO-GAZ SpA、Teleflex Incorporated。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查结果
  • 调查假设
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 吸烟者增加，呼吸系统疾病增加
    • 氧气疗法的技术进步
  • 市场製约因素
    • 严格的监管准则
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品分类
    • 氧源装置
      • 氧气瓶
      • 制氧机
      • 液氧设备
      • 其他
    • 供氧装置
      • 氧气面罩
      • 鼻插管
      • 文丘里面具
      • 非呼吸面罩
      • 其他
  • 通过使用
    • 支气管哮喘
    • 阻塞性睡眠呼吸暂停综合征
    • 慢性阻塞性肺疾病 (COPD)
    • 呼吸窘迫综合征
    • 其他
  • 最终用户
    • 医院
    • 家庭保健
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Allied Healthcare Products, Inc.
    • CAIRE Inc.
    • DeVilbiss Healthcare
    • Fisher & Paykel Healthcare Limited
    • Hersill
    • Invacare Corporation
    • Koninklijke Philips N.V.,
    • Smiths Medical
    • TECNO-GAZ SpA
    • Teleflex Incorporated

第7章 市场机会今后动向

简介目录
Product Code: 66833

The major factors for the growth of the oxygen therapy equipment market include the increase in tobacco smoking and the rising prevalence of respiratory diseases and technological advancement in oxygen therapy.

The increasing prevalence of respiratory diseases is the major factor expected to drive the overall growth of the market over the forecast period. As per the data published by the World Health Organization (WHO), the Global Burden of Disease Study reports a prevalence of 251 million cases of Chronic Obstructive Pulmonary Disease (COPD) globally in 2016. The cases of COPD is likely to increase globally owing to the higher smoking prevalence and aging populations in many countries.

Furthermore, as per the estimates of the American Academy of Allergy, Asthma & Immunology, in 2016, around 8.3% of children in the United States had asthma. It is the most common chronic disease in children. The major risk factor for most of the respiratory diseases is smoking. In 2016, more than 15 of every 100 US adults aged 18 years or older smoked cigarettes as per the estimates of Centre for Disease Control and Prevention (CDC). Thus, owing to the rising prevalence of respiratory diseases the market is expected to witness huge demand over the forecast period.

Oxygen Therapy Equipment Market Trends

Chronic Obstructive Pulmonary Disorder (COPD) is the Segment by Application expected to hold Largest Market Share over the Forecast Period

Chronic respiratory diseases affect the airways and other parts of the lungs for a long duration of the period. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Chronic respiratory diseases affect more than 1 billion people, globally, as per the Global Asthma report, 2018. COPD, with tobacco smoking as its root cause, has affected a significant part of the world population, as per the WHO. Furthermore, according to a 2017 publication in The Lancet Respiratory Medicine, in 2015, an estimated 3.2 people died from COPD, globally. If the patient has low levels of oxygen owing to COPD in blood then long-term oxygen therapy is used. Thus, the rising prevalence of COPD is expected to create huge demand for oxygen therapy equipments resulting in high growth of the Oxygen Therapy Equipment market.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest oxygen therapy equipment market owing to the rising prevalence of respiratory diseases and the presence of better healthcare infrastructure. Also, there is a rise in per capita health expenditure in the country which is expected to increase over the forecast period owing to the decrease in the unemployment rate. The major risk factor for most of the respiratory diseases is smoking. In 2016, more than 15 of every 100 US adults aged 18 years or older smoked cigarettes as per the estimates of the Centre for Disease Control and Prevention (CDC). The cases of COPD is likely to increase in the United States owing to the higher smoking prevalence and aging populations in the country. Over the last decades, there have been significant advances in oxygen concentrator design and functionality. The newer generation of portable oxygen concentrators is designed to be lightweight, quiet, and energy-efficient. Owing to associated advantages of compact size, lower cost, and convenience to carry, the use of portable oxygen contractors have been growing rapidly. Thus, owing to the all above mentioned factors the market is expected to witness high growth.

Oxygen Therapy Equipment Market Competitor Analysis

The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are Allied Healthcare Products, Inc., CAIRE Inc., DeVilbiss Healthcare, Fisher & Paykel Healthcare Limited, Hersill, Invacare Corporation, Koninklijke Philips N.V., Smiths Medical, TECNO-GAZ SpA, and Teleflex Incorporated

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Tobacco Smoking and Rising Prevalence of Respiratory Diseases
    • 4.2.2 Technological Advancement in Oxygen Therapy
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Guidelines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Oxygen Source Equipment
      • 5.1.1.1 Oxygen Cylinders
      • 5.1.1.2 Oxygen Concentrators
      • 5.1.1.3 Liquid Oxygen Devices
      • 5.1.1.4 Others
    • 5.1.2 Oxygen Delivery Devices
      • 5.1.2.1 Oxygen Masks
      • 5.1.2.2 Nasal Cannula
      • 5.1.2.3 Venturi Masks
      • 5.1.2.4 Non-rebreather Masks
      • 5.1.2.5 Others
  • 5.2 By Application
    • 5.2.1 Asthma
    • 5.2.2 Obstructive Sleep Apnea
    • 5.2.3 Chronic Obstructive Pulmonary Disorder (COPD)
    • 5.2.4 Respiratory Distress Syndrome
    • 5.2.5 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Home Healthcare
    • 5.3.3 Ambulatory Surgical Centers
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allied Healthcare Products, Inc.
    • 6.1.2 CAIRE Inc.
    • 6.1.3 DeVilbiss Healthcare
    • 6.1.4 Fisher & Paykel Healthcare Limited
    • 6.1.5 Hersill
    • 6.1.6 Invacare Corporation
    • 6.1.7 Koninklijke Philips N.V.,
    • 6.1.8 Smiths Medical
    • 6.1.9 TECNO-GAZ SpA
    • 6.1.10 Teleflex Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS